Solid Biosciences SLDB 深 沪
等待开盘 08-17 09:30:00 美东时间
9.20
+0.120
+1.32%
华盛通- 最 高9.345
- 今 开9.09
- 成交量 75.94万股
- 最 低 8.73
- 昨 收 9.08
- 总市值 9.86亿
- 52周最高 11.45
- 市盈率 静 --
- 换手率 0.71%
- 52周最低 3.79
- 委 比 -89.42%
- 总股本 1.07亿
- 历史最高 822.60
- 量 比 0.84
- 振 幅 6.77%
- 历史最低 1.81
- 每 手 1
- 风险率 1.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday. Shares of Airsculpt Technologies Inc (NASDAQ:AIRS) fell sharply in pre-market trading following second-quarter results. AirSculpt Technologies posted second-quarter adjusted earnings of 1 cent per share, ...
08-10 20:02
Solid Biosciences Q2 EPS $(0.38) Beats $(0.46) Estimate
Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.46) by 17.39 percent. This is a 9.52 percent increase over losses of $(0.42) per share from the same period last year.
08-07 06:26
Solid Biosciences Updates Shelf for $200 Million Offering
Solid Biosciences ( ($SLDB) ) has shared an update. Solid Biosciences Inc. on A...
08-07 06:20
Solid Biosciences Files Prospectus To Offer Up To $200M In Common Stock
Solid Biosciences Files Prospectus To Offer Up To $200M In Common Stock
08-07 05:29
Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining over 100 points on Wednesday. Shares of Sophia Genetics SA (NASDAQ:SOPH) fell sharply in pre-market trading. Sophia Genetics priced its underwritten public offering of 10.526 million ordinary shares at $4.75 each, ra...
06-17 20:03
美股大行评级 | 火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元
火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元；犹他美容(ULTA)惨遭12家大行下调目标价>>
06-04 11:36
HC Wainwright & Co. Maintains Buy on Solid Biosciences, Raises Price Target to $25
HC Wainwright & Co. analyst Arthur He maintains Solid Biosciences (NASDAQ:SLDB) with a Buy and raises the price target from $20 to $25.
06-03 19:58
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Solid Biosciences Inc. granted 6,580 restricted stock units (RSUs) to a newly hired employee. The RSUs vest in four equal installments annually over four years, contingent on continued employment. The grant was made under the Company’s 2024 Inducement Stock Incentive Plan to induce the employee’s acceptance of employment. Solid Biosciences, a precision genetic medicine company, focuses on developing gene therapy candidates for rare neuromuscular ...
06-01 20:05
美股大行评级 | 花旗上调英特尔目标价至130美元；大摩上调英伟达目标价至285美元；National 、Yesway获多家大行首予买入评级
今日重点评级关注：TD Cowen：维持Strive"买入"评级，目标价从28美元升至30美元；蒙特利尔银行：维持KinderCare Learning"跑赢大市"评级，目标价从4美元升至6美元
05-19 10:55
Wedbush Reiterates Outperform on Solid Biosciences, Maintains $16 Price Target
Wedbush analyst Laura Chico reiterates Solid Biosciences (NASDAQ:SLDB) with a Outperform and maintains $16 price target.
05-18 20:34
